Top Madison, WI Biotech Startups (2,281)
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Formation Bio is a tech-driven pharma company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes all aspects of drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data capture. Formation Bio acquires clinical-stage drugs from pharma and biotech and develops them faster and more efficiently, unlocking greater...
At Inato, we’re on a mission to accelerate the pace of medical innovation by bringing clinical research to each and every patient, regardless of who they are and where they live. Our platform, made to connect community-based research centers to trials across the globe, aims to create greater visibility, access, and engagement across a more diverse population of doctors and...
Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics. We provide affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech,...
Imperative Care is a Silicon Valley-based medical technology company focused on developing the next generation of innovative solutions to address the vast and urgent needs in stroke intervention and peripheral thrombectomy. With a physician-driven approach and a culture of rapid innovation, we are working to improve every aspect of the stroke procedure with the goal of bringing patients the best...
We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based...
Fertilis is pioneering micro-medical technology to automate IVF, focusing on improving embryo quality and quantity. Our primary goal is to develop medical devices that enhance the quality of embryos in IVF treatments.
We are a team of world-class engineers and scientists that provides testing, analysis, and other consulting services to companies across the globe. Biocore’s mission is to provide the highest level of engineering and analytics expertise to clients dedicated to the understanding and reduction of injury. We do this by performing influential and highly-cited research, maintaining state-of-the-art testing capabilities, and leveraging...
NanoSyrinx is a cutting-edge synthetic biology company creating the next generation of targeted drug delivery systems to address challenges in the biologic delivery sector.
Protalix (NYSE, TASE: PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx®. Protalix was the first company to gain FDA approval of a protein produced through plant cell-based in suspension expression system. Protalix's unique expression system represents a new method for developing recombinant proteins in...
Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.
Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.
A Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures.
IAG, Image Analysis Group is a unique partner to life sciences companies, leading AI-powered drug development and precision medicine. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and...
A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products...
Defining and optimising TBI diagnosis and prognosis to maximise patient outcomes.To increase the understanding of brain related injury with particular emphasis on concussion (mTBI) through ongoing research and education, and to ultimately validate a biomarker(s) that will be used in combination with dedicated point of care (POC) device as a definitive diagnostic/prognostic tool. A group of dedicated professionals working in collaboration...
Helix is a rapidly growing startup focused on personal genomics. Helix has a simple but powerful mission: to empower every person to improve their life through DNA. We’re creating an ecosystem where people can explore diverse and uniquely personalized applications provided by high-quality partners.
Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads. In June 2020, Carmine inked a research alliance with Takeda Pharmaceuticals worth up to $900 million to develop non-viral gene therapies for 2 targets. Carmine has also been named one of the FierceBiotech’s Fierce...
